Preliminary reports suggested that hepatitis C virus (HCV) infection has a more aggressive course following living donor liver transplantation (LDLT) compared to cadaveric liver transplantation (CLT). The aim of this prospective study was to establish if HCV disease recurrence differs between LDLT a
Is severe recurrent hepatitis C more common after adult living donor liver transplantation?
โ Scribed by Mark W. Russo; Roshan Shrestha
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 79 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
โฆ Synopsis
No differences between LDLT and DD
Shiffman 1 23 USA, single center yes No patients developed cirrhosis on liver biopsy @ 3 years Russo 10 279 USA, UNOS database no 2-year graft survival 72% LDLT and 75% DD Bozorgzadeh 11 35 USA, single center no No difference in HCV recurrence on liver biopsy Gordon 5 (abstract) 19 USA, single center no Survival 92% in both groups at 36 months Pan 7 (abstract) 15 USA, single center no HCV recurrence on liver biopsy 47% LDLT vs. 65% DD Fahmy 8 (abstract) 33 USA, single center no Graft loss from recurrent hepatitis C 3% LDLT vs. 7.7% DD Vlierberghe 9 (abstract) 17 Belgium, Italy no HCV recurrence on liver biopsy 35% LDLT vs. 38% DD Trotter 4 (abstract) 41 USA, 2 centers no No difference in rate of graft loss from HCV in LDLT and DD group LDLT worse Garcia-Retortillo 12 22 Spain yes Cirrhosis or decompensated liver disease in 45% LDLT vs. 22% DD at 2 years, P ฯญ .019 Gaglio 6 23 USA, single center no HCV recurrence on liver biopsy, graft failure were similar in LDLT and DD group, cholestatic hepatitis higher in LDLT group, 17% vs. 0%, P ฯญ .001 Ghobrial 3 (abstract) 9 USA, single center no HCV recurrence on liver biopsy in 86% LDLT vs. 30% DD, P ฯญ .004
๐ SIMILAR VOLUMES
Hepatitis C virus (HCV) recurs in nearly all patients after liver transplantation. This recurrence is associated with progressive fibrosis and graft loss. It remains unclear whether the natural course of HCV recurrence is altered in patients who undergo living donor liver transplantation (LDLT). We
Only a subset of hepatitis C virus (HCV)-infected patients develop progressive hepatic fibrosis after liver transplantation (LT). Hepatic stellate cell (HSC) activation is a pivotal step in hepatic fibrosis and precedes clinically apparent fibrosis. We determined whether early HSC activation, measur
Hepatitis C recurs universally after liver transplantation (LT). Whether its progression differs after live donor liver transplantation (LDLT) and deceased donor liver transplantation (DDLT) is still debated. We retrospectively analyzed 201 consecutive LTs performed at our institution for hepatitis
Liver transplantation is regarded as an effective treatment for early hepatocellular carcinoma (HCC). However, some patients experience recurrence and subsequently rapid progression of the disease. We investigated prognostic factors affecting survival after recurrence in patients who underwent adult